Evolution of KRAS molecular glues: from allele-selective to Pan-RAS and protein-protein interaction modulators
{{output}}
The successful development of KRASG12C mutation-specific covalent inhibitors made direct targeting of KRAS a reality, yet the limitations in mutational coverage and susceptibility to resistance have spurred the pursuit of broader and more durable strategies. T... ...
